Innoviva Q2 EPS $(0.55) Misses $0.23 Estimate, Sales $99.90M Beat $74.69M Estimate
Portfolio Pulse from Benzinga Newsdesk
Innoviva (NASDAQ:INVA) reported a Q2 EPS of $(0.55), missing the $0.23 estimate by 339.13%, and a 2850% decrease from last year's $0.02 EPS. However, sales were $99.90M, beating the $74.69M estimate by 33.75% and increasing 23.34% from last year's $80.99M.
July 31, 2024 | 9:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Innoviva reported a significant EPS miss of $(0.55) against the $0.23 estimate, a 2850% decrease from last year. However, sales were strong at $99.90M, beating estimates by 33.75% and increasing 23.34% from last year.
The significant EPS miss and drastic decrease from last year's EPS will likely have a negative impact on the stock price in the short term, despite the strong sales performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100